Heart transplantation is widely regarded as the greatest
therapeutic option for individuals with end-stage heart failure across the
world. Only a limited percentage of patients get transplants due to the
scarcity of organs available for transplantation. According to the most recent
statistics, the number of patients waiting for a heart transplant has more than
doubled in only five years. However, the scarcity of donors, long waiting
times, and an increasing number of unstable patients have favored the
development of cardiac assist.
Get detailed information @ Cardiac Assist Devices Market Insights
Cardiac Assist Devices (CAD) are a type of mechanical pump
that operate together with the heart to increase the effectiveness of pumping
and maintain optimal blood flow across the body. To treat end-stage heart
failure, cardiac aid systems are used that are determined by the individual's
needs. As a result of the scarcity of cardiac donors, temporary cardiac assist
devices are utilized to provide long-term assistance for individuals.
As per the Centers for Disease Control and Prevention (CDC),
in 2020, certain risk factors like coronary artery disease (CAD), heart
attacks, diabetes, high blood pressure, and obesity increases the risk for
heart failure. According to a report from the American Heart Association, 2020,
the prevalence of heart failure continues to increase over time, with the aging
of the population. An estimated 6.2
million American adults ≥20 years of age had heart failure between
2013 and 2016, compared with an estimated 5.7 million between 2009 and 2012.
Original Source:- Cardiac Assist Devices Competitive Landscape
Comments
Post a Comment